Alexander Nguyen

Alexander Nguyen has extensive experience in non-clinical and clinical operations, regulatory affairs, and study management. Alexander currently works at REVOLUTION Medicines as the Director of Non-Clinical Operations, where they manage the non-clinical operations group and oversees outsourced toxicology studies. Prior to this role, they worked at Flexion Therapeutics as a Manager to Senior Operations Manager, overseeing outsourced toxicology and clinical studies. Alexander has also held positions at ImmunoCellular Therapeutics Ltd, UCLA, Medivation, Westlake Medical Research/WMR Clinical Trials, and Amgen, where they gained experience in clinical and regulatory operations, study monitoring, and project management. Additionally, they worked independently as a contract study monitor and started their career at Merck and Rhone-Poulenc Rorer (Sanofi-Aventis) as a staff biologist and research scientist, respectively.

Alexander Nguyen attended Temple University, where they earned a Bachelor of Science (BS) degree in Biology. Alexander also obtained a certification in Good Clinical Practice (GCP) through the CITI Program, a division of BRANY. No specific information regarding the start or end years of their education or the month and year of obtaining their certification is provided.